Pacira BioSciences, Inc. (PCRX) Social Stream



Pacira BioSciences, Inc. (PCRX): $49.28

-0.41 (-0.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PACIRA BIOSCIENCES INC (PCRX) Price Targets From Analysts

Use the tables below to see what analysts covering PACIRA BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 12 $93 $54 $80.916 $48.8 65.81%
2021-12-08 12 $93 $54 $81.083 $48.8 66.15%
2021-12-10 12 $97 $54 $81.416 $48.8 66.84%
2022-01-07 13 $97 $54 $81.538 $48.8 67.09%
2022-01-13 13 $97 $54 $81.846 $48.8 67.72%
2022-02-25 13 $97 $54 $82.153 $48.8 68.35%
2022-03-01 13 $96 $54 $82.615 $48.8 69.29%
2022-04-14 11 $96 $54 $81.363 $48.8 66.73%
2022-05-05 11 $96 $54 $81.6 $48.8 67.21%
2022-05-13 10 $96 $54 $81.6 $48.8 67.21%
2022-06-01 9 $96 $54 $83.222 $48.8 70.54%
2022-06-15 8 $96 $54 $82.125 $48.8 68.29%
2022-07-21 8 $96 $54 $81.625 $48.8 67.26%
2022-08-01 8 $96 $54 $81.125 $48.8 66.24%
2022-08-02 8 $96 $54 $80.75 $48.8 65.47%
2022-08-04 8 $96 $54 $80.142 $48.8 64.23%
2022-09-21 8 $96 $54 $80.125 $48.8 64.19%
2022-10-13 7 $96 $54 $80.125 $48.8 64.19%
2022-10-17 7 $96 $54 $79.25 $48.8 62.4%
2022-11-02 8 $96 $54 $77.777 $48.8 59.38%
2022-11-04 9 $96 $54 $75.333 $48.8 54.37%
2022-11-15 9 $96 $54 $73.5 $48.8 50.61%

The Trend in the Analyst Price Target


Over the past 21 months, PCRX's average price target has gone up $0.64.

PCRX reports an average of 36.71% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-13 13 97 54 81.846 61.33 33.45%
2022-01-20 13 97 54 82.153 64.00 28.36%
2022-03-01 11 96 54 82.615 67.67 22.09%
2022-05-05 11 96 54 80.545 63.93 25.99%
2022-10-13 7 96 54 80.125 54.00 48.38%

PCRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.56 6 1 2 0 0 9

The Trend in the Broker Recommendations


Over the past 153 days, PCRX's average broker recommendation rating worsened by 0.18.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PCRX as an investment opportunity.

  • PACIRA BIOSCIENCES INC's average analyst price target is higher than 2405.73% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PACIRA BIOSCIENCES INC's number of analysts covering the stock is higher than 2202.03% of them.
  • PCRX has a higher upside potential (average analyst target price relative to current price) than 807.15% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, PACIRA BIOSCIENCES INC's variance in analysts' estimates is lower than -1008.48% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PACIRA BIOSCIENCES INC are EBS, SUPN, and PBH.

Is PCRX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8802 seconds.